Should we rename low risk cancers?

Advanced Search

Laura J Esserman, Murali Varma

Author Information

Laura J Esserman: UCSF Carol Franc Buck Breast Care Center, San Francisco, CA, USA laura.esserman@ucsf.edu.
Murali Varma: Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK laura.esserman@ucsf.edu.

PMID: 30674473 DOI: 10.1136/bmj.k4699

No abstract text available.

Disease Progression

Female

Humans

Incidence

Male

Neoplasms

Recurrence

Risk

Terminology as Topic

Journal Article

OpenLB
Open Library of Bioscience